Roivant Sciences Ltd (ROIV)

Debt-to-equity ratio

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Long-term debt	US$ in thousands	204,371	194,560	188,911	187,140	180,700	183,510	188,680	200,700	210,025	204,042	199,869	186,350
Total stockholders’ equity	US$ in thousands	5,968,580	6,089,760	948,534	910,730	1,157,770	955,520	1,160,600	1,384,110	1,656,940	1,865,720	2,038,020	1,723,120
Debt-to-equity ratio		0.03	0.03	0.20	0.21	0.16	0.19	0.16	0.15	0.13	0.11	0.10	0.11

March 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $204,371K ÷ $5,968,580K
= 0.03

The debt-to-equity ratio of Roivant Sciences Ltd has been relatively stable over the past few quarters, ranging between 0.03 and 0.21. The company's debt levels relative to its equity have been low, indicating a conservative approach to financing its operations. The ratios have shown a slight increase in the most recent quarters compared to the earlier periods, suggesting a potential increase in debt or decrease in equity. Overall, the company's debt-to-equity ratio indicates a healthy balance between debt and equity financing, providing a solid financial foundation for its operations.